Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation

Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation

The aim of this study was to evaluate whether blood transfusions affect overall survival (OS) and progression-free survival (PFS) in newly diagnosed multiple myeloma (MM) patients without hematopoietic stem cell transplantation. A total of 181 patients were enrolled and divided into two groups: 68 p...

Full description

Bibliographic Details
Main Authors:	Liping Fan, Danhui Fu, Jinping Zhang, Haobo Huang, Qingqing Wang, Yamei Ye, Qianling Xie
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/5462087

Similar Items

Prognostic Significance of Blood Transfusion in Elderly Patients with Primary Diffuse Large B-Cell Lymphoma
by: Liping Fan, et al.
Published: (2018-01-01)

Evaluation of the UK Myeloma Research Alliance Risk Profile in Chinese Patients with Newly Diagnosed Multiple Myeloma without Autologous Stem Cell Transplantation
by: Ma K, et al.
Published: (2021-04-01)

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
by: Sarah A. Bird, et al.
Published: (2020-05-01)

Clinical significance of granule‐containing myeloma cells in patients with newly diagnosed multiple myeloma
by: Kazuhito Suzuki, et al.
Published: (2016-11-01)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Yue Zhang, et al.
Published: (2019-01-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma
by: Virginia Bove, et al.
Published: (2021-07-01)

Newly diagnosed multiple myeloma in Taiwan
by: Chung-King Lin, et al.
Published: (2009-07-01)

Incidental Discovery of Multiorgan Extramedullary Plasmacytomas in the Setting of Newly Diagnosed Multiple Myeloma and Delayed Hemolytic Transfusion Reaction
by: Joselle Cook, et al.
Published: (2017-01-01)

Efficacy and prognostic factors of autologous hematopoietic stem cell transplantation for multiple myeloma: clinical analysis of 53 cases
by: HE Renke, et al.
Published: (2021-03-01)

Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
by: Doaa A. Mohammed, et al.
Published: (2021-06-01)

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis
by: Francesca Bonello, et al.
Published: (2019-11-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

Daratumumab in untreated newly diagnosed multiple myeloma
by: Nadine Abdallah, et al.
Published: (2019-12-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: S. A. Tuchman, et al.
Published: (2012-01-01)

Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma
by: Ying Tian, et al.
Published: (2018-01-01)

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
by: Chuanying Geng, et al.
Published: (2021-01-01)

Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients
by: EL Nazarova, et al.
Published: (2018-01-01)

Sequential, autologous hematopoietic stem cell transplant followed by renal transplant in multiple myeloma
by: D Bhowmik, et al.
Published: (2017-01-01)

Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
by: Rahul Naithani, et al.
Published: (2020-10-01)

Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
by: Mir Sadaqat Hassan Zafar, et al.
Published: (2018-01-01)

Changing landscape of induction therapy in newly diagnosed multiple myeloma
by: Nidhi Tandon, et al.
Published: (2019-01-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
by: JingSong He, et al.
Published: (2021-07-01)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
by: Qianwen Cheng, et al.
Published: (2021-03-01)

Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients
by: Dăscălescu, A.S, et al.
Published: (2022)

Survival Analysis of Total Therapy 3 in Newly Diagnosed Multiple Myeloma
by: Miller, Scott Edward Bowman
Published: (2015)

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.
by: Jingsong He, et al.
Published: (2014-01-01)

Identifying responders to melphalan and dexamethasone for newly diagnosed multiple myeloma patients
by: Esmaeili, Abbas
Published: (2008)

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
by: Mattia D’Agostino, et al.
Published: (2021-04-01)

Autologous Transfusion in Cardiac Surgery
by: Radmehr H, et al.
Published: (2003-11-01)

Clinical prognostic factors in newly diagnosed glioblastoma
by: Ionela Bizu, et al.
Published: (2019-06-01)

Management of central nervous system involvement in multiple myeloma after autologous hematopoietic stem cell transplantation
by: Khatereh Mousavi-Fatemi, et al.
Published: (2020-01-01)

Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients
by: A. S. Rosenberg, et al.
Published: (2021-01-01)

Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma.
by: Nuri Lee, et al.
Published: (2021-01-01)

Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
by: Asmaa M. Zahran, et al.
Published: (2021-08-01)

Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients
by: Nilgun Ozbek Okumus, et al.
Published: (2012-05-01)